MOBXMobix Labs, Inc.
The schedule
- Thu15Oct
As the share price decays into penny-stock territory, Mobix risks triggering Nasdaq minimum bid price deficiency notices, forcing management to address delisting risks through technical measures such as a reverse stock split.
- Wed11Nov
- Thu12Nov
The late-year earnings update will require MOBX to map out its 2027 viability, detailing how its remaining capital aligns with AI hardware and next-generation connectivity deployment timelines.
- Thu11Feb
Mobix's first report of 2027 will likely center around aggressive cost-cutting measures, comprehensive restructuring efforts, or potential strategic M&A alternatives if standalone operations fail to generate sustainable cash flow.
- Wed12May
- Wed11Aug
Past
- Thu13Aug
The mid-summer earnings print will serve as a referendum on the company's survival and operational execution. With revenue previously plummeting over 40% year-over-year, investors will demand concrete proof of a turnaround.
- Wed12Aug
- Wed22Jul
Assuming financing is secured, MOBX is expected to provide updates on its 5G and IoT custom silicon pipeline in an attempt to re-engage market enthusiasm and shift focus away from its debt burden.
- Thu18Jun
Mobix Labs enters the summer with a critically depleted cash runway, having reported just $268k in cash at the end of 2025 alongside a negative operating cash flow of $4.76M. A highly dilutive secondary offering or toxic debt structure is a near certainty to bridge this severe financing gap.
- Thu14May
Actual outcome: Bear · $1.90 at outcome
Mobix Labs reported in-line EPS of -$2.20 and announced the strategic acquisition of a U.S. defense rare earth and critical minerals company. However, the stock fell 34.4% as investors reacted negatively to the amendment of a senior secured convertible note that increased its principal to $4 million for an $833,000 cash advance, raising dilution and financing concerns despite the debt later being extinguished.
Fiscal Q2 earnings with shares at $1.74, facing severe liquidity risks with a $3.10 target and $0.85 fallback.
